SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million

Reuters

2025/11/07

SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million

SciBase Holding AB reported net sales of SEK 10.3 million for the third quarter of 2025, an increase of 23% compared to SEK 8.4 million in the same period of 2024. The loss after tax was SEK 18.8 million, compared to a loss of SEK 17.8 million in the previous year. Loss per share for the quarter was SEK 0.05, down from SEK 0.08. The gross margin was 60.0%, compared to 75.7% in the previous year. Electrode sales volume rose by 24% to 21,278 units, with repeat sales to existing customers increasing by 33%. For the first nine months of 2025, net sales reached SEK 28.0 million, up 33% from SEK 21.1 million in 2024, and the gross margin was 65.3%. Cash flow from current operations was negative at SEK 17.3 million for the quarter. After the end of the period, SciBase expanded its collaboration and license agreement with Castle Biosciences, entered into a loan agreement, and the Board resolved on a rights issue of approximately SEK 83 million and an offer to convert outstanding TO2 warrants into shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2581713130"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581713130\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581713130?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 15:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581713130","market":"nz","top_or_hot":-1,"title":"SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SciBase Holding AB reported net sales of SEK 10.3 million for the third quarter of 2025, an increase of 23% compared to SEK 8.4 million in the same period of 2024. The loss after tax was SEK 18.8 million, compared to a loss of SEK 17.8 million in the previous year. Loss per share for the quarter was SEK 0.05, down from SEK 0.08. The gross margin was 60.0%, compared to 75.7% in the previous year. Electrode sales volume rose by 24% to 21,278 units, with repeat sales to existing customers increasing by 33%. For the first nine months of 2025, net sales reached SEK 28.0 million, up 33% from SEK 21.1 million in 2024, and the gross margin was 65.3%. Cash flow from current operations was negative at SEK 17.3 million for the quarter. After the end of the period, SciBase expanded its collaboration and license agreement with <a href=\"https://laohu8.com/S/CSTL\">Castle Biosciences</a>, entered into a loan agreement, and the Board resolved on a rights issue of approximately SEK 83 million and an offer to convert outstanding TO2 warrants into shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-07 15:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SciBase Holding AB reported net sales of SEK 10.3 million for the third quarter of 2025, an increase of 23% compared to SEK 8.4 million in the same period of 2024. The loss after tax was SEK 18.8 million, compared to a loss of SEK 17.8 million in the previous year. Loss per share for the quarter was SEK 0.05, down from SEK 0.08. The gross margin was 60.0%, compared to 75.7% in the previous year. Electrode sales volume rose by 24% to 21,278 units, with repeat sales to existing customers increasing by 33%. For the first nine months of 2025, net sales reached SEK 28.0 million, up 33% from SEK 21.1 million in 2024, and the gross margin was 65.3%. Cash flow from current operations was negative at SEK 17.3 million for the quarter. After the end of the period, SciBase expanded its collaboration and license agreement with <a href=\"https://laohu8.com/S/CSTL\">Castle Biosciences</a>, entered into a loan agreement, and the Board resolved on a rights issue of approximately SEK 83 million and an offer to convert outstanding TO2 warrants into shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健護理服務","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL766P6l:1","article_id":"2581713130","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581713130","pubTimestamp":1762500802,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"SciBase Holding AB reported net sales of SEK 10.3 million for the third quarter of 2025, an increase of 23% compared to SEK 8.4 million in the same period of 2024. The loss after tax was SEK 18.8 million, compared to a loss of SEK 17.8 million in the previous year. Loss per share for the quarter was SEK 0.05, down from SEK 0.08. The gross margin was 60.0%, compared to 75.7% in the previous year. Electrode sales volume rose by 24% to 21,278 units, with repeat sales to existing customers increasing by 33%. For the first nine months of 2025, net sales reached SEK 28.0 million, up 33% from SEK 21.1 million in 2024, and the gross margin was 65.3%. Cash flow from current operations was negative at SEK 17.3 million for the quarter. After the end of the period, SciBase expanded its collaboration and license agreement with Castle Biosciences, entered into a loan agreement, and the Board resolved on a rights issue of approximately SEK 83 million and an offer to convert outstanding TO2 warrants i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","CSTL":"Castle Biosciences, Inc."},"translate_title":"SciBase Holding AB报告第三季度净销售额为1030万瑞典克朗，税后亏损为1880万瑞典克朗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSTL":0.9},"content_text":"SciBase Holding AB reports Q3 net sales of SEK 10.3 million and loss after tax of SEK 18.8 million\n    \n\n        SciBase Holding AB reported net sales of SEK 10.3 million for the third quarter of 2025, an increase of 23% compared to SEK 8.4 million in the same period of 2024. The loss after tax was SEK 18.8 million, compared to a loss of SEK 17.8 million in the previous year. Loss per share for the quarter was SEK 0.05, down from SEK 0.08. The gross margin was 60.0%, compared to 75.7% in the previous year. Electrode sales volume rose by 24% to 21,278 units, with repeat sales to existing customers increasing by 33%. For the first nine months of 2025, net sales reached SEK 28.0 million, up 33% from SEK 21.1 million in 2024, and the gross margin was 65.3%. Cash flow from current operations was negative at SEK 17.3 million for the quarter. After the end of the period, SciBase expanded its collaboration and license agreement with Castle Biosciences, entered into a loan agreement, and the Board resolved on a rights issue of approximately SEK 83 million and an offer to convert outstanding TO2 warrants into shares.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief on November 07, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}